1 insider bought €60k of shares over the last 90 days, the latest by Laurent GUILLOT, filed 22 Sept 2026.
Every trade that managers of Emeis disclose to AMF is tracked on this page. The company sits in the Healthcare & Pharma sector and is based in Puteaux, France. It was founded in 1989. The last twelve months, up to 23 October 2026, brought 4 filings signed by 2 insiders.
Only purchases show up on the open market, 4 purchases in all worth €179k, filed by 2 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 1 senior executive and 1 chief executive. The largest single trade was a purchase of €71k by Laurent GUILLOT, published on 15 June 2026, equal to 0.0030% of the market capitalisation.
In the case of 2 purchases, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 22 September 2026, 33 days ago. Filings reach the AMF feed a median of 5 days after the trade. The regulation allows three business days to notify a trade (MAR article 19).
Compared with its exchange (313 companies, median 7 filings), a count of 4 filings is below the norm. Looking back to 2021, when coverage begins, insiders filed 19 purchases and 3 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from AMF. Past trades are no guide to future returns.
Headquarters: Puteaux, France · Founded: 1989 · 49,185 employees (2016)
Source: Wikidata (CC0).
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 30 declarations
emeis is a major European healthcare and care-services group focused on supporting vulnerable people. Listed on Euronext Paris under ISIN FR001400NLM4, the company is the renamed successor of Orpea, which adopted the emeis identity in March 2024 to signal the opening of a new chapter in its corporate history. In June 2025, the group took another important step by becoming a mission-driven company, embedding four statutory commitments: changing perceptions of vulnerable people and their families, improving the recognition and attractiveness of its professions, strengthening local social cohesion, and innovating to deliver care that is more respectful of the planet and living beings. This evolution reflects a broader effort to rebuild trust, reshape governance and reinforce the company’s long-term social purpose.
Historically, the group built its business around long-term care for elderly people before expanding into a wider range of health and support services. Today, emeis operates across five core areas of expertise: psychiatric clinics, medical and rehabilitation clinics, nursing homes, home care and support services, and assisted living facilities. Each year, the group welcomes nearly 280,000 residents, patients and beneficiaries, supported by around 83,500 professionals working in care, hospitality and support functions. This scale gives emeis meaningful operational depth in a sector where quality of service, local presence and clinical expertise are essential competitive factors.
emeis has a broad international footprint. The group is present in around 20 countries across Europe and beyond, including France, Germany, Belgium, Spain, Italy, Portugal, Switzerland, the United Kingdom, Central Europe, Latin America and China. Its network comprises more than 1,000 facilities and more than 50 brands, each anchored in local markets. This diversified geographic base helps emeis address structural demand drivers such as population ageing, rising mental-health needs and the increasing need for rehabilitation and long-duration care.
From an equity-market perspective, emeis is controlled 50.3% by Caisse des Dépôts, CNP Assurances, MAIF and MACSF Epargne Retraite, and is included in the SBF 120, CAC Mid 60 and CAC All-Tradable indices. The group has also been actively reshaping its asset portfolio, pursuing targeted disposals to strengthen its balance sheet and improve financial flexibility. Its 2025 results, published in April 2026, showed a strong improvement in operating performance and margins, supporting the view that the turnaround is gaining traction. Overall, emeis stands out as a large-scale European care platform in transition, combining essential healthcare services, a wide geographic reach and a renewed strategic focus on sustainable, people-centered growth.
Purchases our model currently ranks for the recommendations list.
All recommendations